Conduction Heterogeneity: Impact of Underlying Heart Disease and Atrial Fibrillation by Heida, A. (Annejet) et al.
J A C C : C L I N I C A L E L E C T R O P H Y S I O L O G Y VO L . 6 , N O . 1 4 , 2 0 2 0
ª 2 0 2 0 T H E A U T H O R S . P U B L I S H E D B Y E L S E V I E R O N B E H A L F O F T H E AM E R I C A N
C O L L E G E O F C A R D I O L O G Y F O U N DA T I O N . T H I S I S A N O P E N A C C E S S A R T I C L E U N D E R
T H E C C B Y - N C - N D L I C E N S E ( h t t p : / / c r e a t i v e c o mm o n s . o r g / l i c e n s e s / b y - n c - n d / 4 . 0 / ) .Conduction Heterogeneity
Impact of Underlying Heart Disease and Atrial FibrillationAnnejet Heida, MD,a Willemijn F.B. van der Does, MD,a Lianne N. van Staveren, MD,a
Yannick J.H.J. Taverne, MD, PHD,b Maarten C. Roos-Serote, PHD,a Ad J.J.C. Bogers, MD, PHD,b






MaOBJECTIVES The goal of this study is to investigate the impact of various underlying heart diseases (UHDs) and prior
atrial fibrillation (AF) episodes on conduction heterogeneity.
BACKGROUND It is unknown whether intra-atrial conduction during sinus rhythm differs between various UHD or is
influenced by AF episodes.
METHODS Epicardial sinus rhythm mapping of the right atrium, Bachmann’s bundle (BB), left atrium and pulmonary
vein area was performed in 447 participants (median age: 67 [interquartile range (IQR): 59 to 73] years) with or without
AF undergoing cardiac surgery for ischemic heart disease, (ischemic and) valvular heart disease, or congenital heart
disease. Conduction times (CTs) were defined as D local activation time between 2 adjacent electrodes and used to assess
frequency (CTs $ 4 ms) and magnitude of conduction disorders (in increments of 10 ms).
RESULTS When comparing the 3 types of UHD, there were no differences in frequencies and magnitude of CTs at all
locations (p $ 0.017 and p $ 0.005, respectively). Prior AF episodes were associated with conduction slowing
throughout both atria (14.9% [IQR: 11.8 to 17.0] vs. 12.8% [IQR: 10.9 to 14.6]; p < 0.001). At BB, CTs with
magnitudes $30 ms were more common in patients with AF (n ¼ 56.2% vs. n ¼ 36.0%; p < 0.004).
CONCLUSIONS UHD has no impact on the frequency and severity of conduction disorders. AF episodes are associated
with more conduction disorders throughout both atria and with more severe conduction disorders at BB. The next step
will be to determine the relevance of these conduction disorders for AF development and maintenance.
(J Am Coll Cardiol EP 2020;6:1844–54) © 2020 The Authors. Published by Elsevier on behalf of the American College of
Cardiology Foundation. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).I ntra-atrial conduction is determined by mem-brane properties, tissue structure and wavefrontgeometry (1). If there is a loss of cell-to-cell
communication, resulting in enhanced non-uniform
anisotropy, the wavefront geometry will be distorted,
leading to conduction disorders and eventually to
arrhythmias, such as atrial fibrillation (AF) (2,3).
A prior epicardial mapping study in patients with
Wolff-Parkinson White syndrome with nondilated
atria and without a history of AF demonstrated thatN 2405-500X
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AB BR E V I A T I O N S
AND ACRONYM S
AF = atrial fibrillation
BB = Bachmann’s bundle
CHD = congenital heart disease
CT = conduction time
iVHD = (ischemic and) valvular
heart disease
IHD = ischemic heart disease
LA = left atrium
PVA = pulmonary vein area
RA = right atrium
UHD = underlying heart
diseases
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1845disorders in patients with valvular heart disease
(VHD) may be solely due to pressure and/or volume
overload (5). In patients with ischemic heart disease
(IHD), conduction disorders leading to arrhythmias
are, for example, caused by inflammation, athero-
sclerosis, and myocardial infarction (6–8). In patients
with uncorrected congenital heart disease (CHD),
conduction disorders are the result of abnormal
anatomy, altered hemodynamics, and longstanding
pressure and/or volume overload (9).
AF is the most common arrhythmia that itself in-
duces both electrical and structural remodeling
(10,11). Prolonged P-wave duration, as an indicator of
intra-atrial conduction delay, predicts AF recurrences
(12). Previous mapping studies using specific cutoff
values for conduction times (CTs) demonstrated in a
small number of patients that AF episodes resulted in
more conduction delay and conduction block during
sinus rhythm. However, these studies were limited to
the pulmonary vein area (PVA) and Bachmann’s
bundle (BB) (13,14). So far, differences in the preva-
lence and severity of conduction disorders during
sinus rhythm between patients with and without AF
episodes, including all local CTs, throughout the RA,
BB, PVA, and left atrium (LA) have not been reported.
For identifying the arrhythmogenic substrate un-
derlying AF and the causal relation between UHD and
AF, it is essential to understand conduction charac-
teristics between various UHDs and a history of AF
during sinus rhythm. We hypothesize that structural
and electrical remodeled atria not only contain more,
but also more severe conduction disorders during si-
nus rhythm. The aims of this study were therefore: 1)
to distinguish conduction disorders between patients
with IHD, (ischemic and) VHD (iVHD), and CHD; and
2) to determine the influence of AF episodes on con-
duction heterogeneity across the epicardial atrial
surface in a large cohort of patients.SEE PAGE 1855METHODS
STUDY POPULATION. The study population con-
sisted of participants undergoing open-heart surgery.
Indications for surgery were either CHD, IHD, aortic-
or mitral valve disease, or the combination of IHD and
VHD. Additionally, patients were categorized into
groups according to those: 1) with or without a history
of AF; and 2) IHD, CHD, or iVHD patients without an
AF history. The latter group is combined because
previous epicardial mapping studies found no dif-
ferences in total activation time and patterns of
activation between patients with VHD and the com-
bination of ischemic and VHD (15,16). This study isapproved by the institutional Medical Ethical
Committee (MEC 2010-054, MEC 2014-393)
(17,18). Preceding the surgical procedure,
written informed consent was obtained from
all patients. Clinical data were extracted from
electronic patient files.
MAPPING PROCEDURE. High-resolution epicar-
dial mapping during sinus rhythm was per-
formed during open-heart surgery before
extracorporeal circulation (19). A detailed
description of the method is provided in the
Supplemental Methods. When patients were
in AF, electrical cardioversion to sinus
rhythm was performed before the mapping
procedure. Mapping was conducted by shift-
ing the 128- or 192-electrode array (interelectrode
distance 2 mm) in a systemic order along predefined
sites covering the epicardial surface of both atria
(Figure 1, upper left panel), including RA (from the
cavo-tricuspid isthmus up to the RA appendage,
perpendicular to the caval veins), PVA (from the sinus
transversus, alongside the borders of the pulmonary
veins towards the atrioventricular groove), LA (from
the lower border of the left pulmonary vein along the
left atrioventricular groove towards the LA
appendage), and BB (from the tip of LA appendage
behind the aorta towards the superior cavo-atrial
junction).
MAPPING DATA ANALYSIS. The steepest negative
slopes of all atrial potentials were automatically an-
notated. For each electrode, the local activation time
was determined and color-coded activation maps
were reconstructed as shown in the right side of
Figure 1. As previously described in a number of
mapping studies, inter-electrode CTs were calculated
by subtracting the local activation time of each elec-
trode from the adjacent right and lower electrode
(Figure 1, right) (13,14). The 90th percentile of all CTs
was 4.7 ms (4.0 to 5.7 ms) and CTs <4 ms are there-
fore considered as normal atrial conduction. The
frequency of CTs was analyzed per patient as the
median proportion of CT $4 ms. The magnitude of
CTs was defined as the size of inter-electrode differ-
ences in milliseconds and expressed as the percent-
age of patients with different magnitudes of CTs. The
magnitude of CTs was analyzed in 10-ms increments.
STATISTICAL ANALYSIS. All data were tested for
normality. Skewed continuous data were expressed as
median (interquartile range [IQR]); comparison of
continuous data between UHD was performed using
the Kruskal-Wallis test and comparison of continuous
data between patients with and without AF was
FIGURE 1 Methods of Epicardial Mapping
The upper left panel shows mapping sites on a schematic posterior view of the atria. The lower left panel shows unipolar electrogram recordings during 5 s of sinus
rhythm. The right panel shows a color-coded activation map with isochrones (black lines) drawn at 10ms. The black arrow indicates the main wave direction. An example
of determining conduction times (CTs) by subtracting the local activation time (LAT) of each electrode is shown next to the activation map. A ¼ atrial signal;
BB ¼ Bachmann’s bundle; IVC ¼ inferior vena cava; LA ¼ left atrium; LAA ¼ left atrial appendage; PVA ¼ pulmonary vein area; PVL ¼ left pulmonary vein; PVR ¼ right
pulmonary vein; RA ¼ right atrium; RAA ¼ right atrial appendage; SVC ¼ superior vena cava; U ¼ unipolar electrogram recordings; V ¼ ventricular signal.
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1846performed by using the Mann-Whitney U test. Cate-
gorical data are expressed as absolute numbers (per-
centages) and analyzed with chi square or Fisher exact
test if appropriate. Bonferroni correction was applied
for comparison of the UHD (p < 0.0083 [i.e. 0.05/6]),
divided into 3 categories: IHD, iVHD, and CHD
(p < 0.017 [i.e., 0.05/3]). Furthermore, a p < 0.0125
(0.05/4) was considered statistically significant for the
comparison of anti-arrhythmic drug usage. Overall, a
p < 0.05 was considered statistically significant. For
other comparisons that require correction for multiple
testing, corrected p values will be reported. Statistical
analysis was performed with SPSS version 24 (IBM
Corporation, Armonk, New York).RESULTS
CHARACTERISTICS OF PARTICIPANTS. Baseline
characteristics of the study population are shown in
Table 1. Participants either had no history of AF
(n ¼ 372, 83.2%), paroxysmal AF (n ¼ 52, 11.6%),
persistent AF (n ¼ 21, 4.7%), or longstanding persis-
tent AF (n ¼ 2, 0.4%). Patients without a history of AF
were younger than patients with a history of AF
(median age: 67 [interquartile range (IQR): 58 to 77]
years vs. 70 [range 65 to 77] years, respectively;
p < 0.001). The comparison of UHD included IHD
(n ¼ 219, 58.9%), iVHD (n ¼ 121, 32.5%), and CHD
(n ¼ 32, 8.6%). A history of AF was associated with LA
TABLE 1 Characteristics of Participants
Total Group
(n ¼ 447)
No History of AF
(n ¼ 372)
AF
(n ¼ 75) p Value
Age, yrs 67 (59-73) 67 (58-72) 70 (65-77) <0.001
Male 325 (72.7) 280 (75.3) 45 (60.0) 0.007
BMI, kg/m2 27.0 (24.7-30.2) 27.1 (24.9-30.4) 26.9 (24.0-29.6) 0.22
Underlying heart disease <0.001
AVD 60 (13.4) 42 (11.3) 18 (24.0) <0.0083*
AVD and IHD 48 (10.7) 41 (11.0) 7 (9.3) 0.67
IHD 238 (53.2) 219 (58.9) 19 (25.3) <0.0083*
CHD 40 (8.9) 32 (8.6) 8 (10.7) 0.57
MVD 36 (8.1) 19 (5.1) 17 (22.7) <0.0083*
MVD and IHD 25 (5.6) 19 (5.1) 6 (8.0) 0.41
Echocardiography
LVF 0.08
Normal 344 (77.0) 283 (76.1) 61 (81.3)
Mild dysfunction 79 (17.1) 71 (19.1) 8 (10.7)
Moderate dysfunction 20 (4.5) 16 (4.3) 4 (5.3)
Severe dysfunction 4 (0.9) 2 (0.5) 2 (2.7)
Dilated LA >45 mm 98/284 (34.5) 63/224 (28.1) 35/60 (58.3) <0.001
Medication
Antiarrhythmic drugs 0.006
Class I 2 (0.4) 1 (0.3) 1 (1.3) 0.31
Class II 284 (63.5) 239 (64.2) 54 (60.0) 0.49
Class III 23 (5.1) 5 (1.3) 18 (24.0) <0.0125*
Class IV 19 (4.3) 1 (4.6) 2 (2.7) 0.75
Digoxin 11 (2.5) 3 (0.8) 8 (10.7) <0.0125*
Values are median (interquartile range) or n (%). *Bonferroni correction was applied.
AF ¼ atrial fibrillation; AVD ¼ aortic valve disease; BMI ¼ body mass index; CHD ¼ congenital heart disease; IHD ¼ ischemic heart disease; LA ¼ left atrium; LVF ¼ left
ventricular function; MVD ¼ mitral valve disease; UHD ¼ underlying heart disease.
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length during epicardial mapping did not differ
between the 3 UHD (IHD median (IQR) time: 901
[range: 762 to 1023] ms; iVHD median (IQR) time: 835
[range: 721 to 999] ms; CHD median (IQR) time: 866
[range: 734 to 963] ms; p ¼ 0.09) or patients with and
without an history of AF (874 [753 to 1,065] ms vs. 876
[750 to 1,012] ms, respectively; p ¼ 0.46).
IMPACT OF UNDERLYING HEART DISEASES ON
INTRA-ATRIAL CONDUCTION. Figure 2 shows 3 ex-
amples of color-coded activation maps. In the acti-
vation map on the left side of Figure 2, the SR
wavefront does not encounter any areas of conduc-
tion delay. The middle activation map shows slightly
more areas of conduction delay represented by
crowding of isochrones in the lower right part,
whereas in the activation map on the right side of
Figure 2, a large area of conduction delay is present in
the middle left part of the activation map. In these 3
activation maps, CTs $12 ms are 0.3%, 2.1%, and
5.9%, respectively. When comparing the 3 UHDs,
there were no differences in frequencies of CTs $4 ms
(all locations, p $ 0.017).IMPACT OF VARIOUS UHDs ON THE SEVERITY OF
CONDUCTION DISORDERS. Each patient in both
groups had at least a CT $16 ms. Magnitudes of CTs
were comparable between patients with IHD, iVHD,
and CHD throughout both atria (Bonferroni corrected
p $ 0.005) and at each location separately (RA: p $
0.005, BB: p $ 0.004, LA: p $ 0.006, PVA: p $ 0.008,
all Bonferroni corrected).
IMPACT OF AF HISTORY ON INTRA-ATRIAL
CONDUCTION. The upper panel of Figure 3 shows 2
typical examples of color-coded activation maps ob-
tained from a patient without AF and with AF. As
shown in the CT maps, there is only 1 small area of
conduction slowing with a CT of 7 ms (left panel) in
the patient without AF, whereas the patient with AF
has multiple areas of CTs ranging from 7 to even
30 ms (right panel) (11.8% vs. 0.3%).
An AF history was associated with slowing of
conduction; the maximum CT (IQR) for patients in the
AF group ranged from 40 to 66 ms (median: 54 ms),
whereas in patients in the no-AF group, the
maximum CT ranged from 33 to 54 ms (median:
45 ms) (p ¼ 0.006).
FIGURE 2 Color-Coded Activation Maps Showing Conduction Disorders
Examples of color-coded activation maps. In the left activation map, the sinus rhythm wavefront propagates and encounters only 1 small area
of conduction delay. Themiddle activation map has slightly more areas of conduction delay represented by crowding of isochrones in the lower
right part of the activation map, whereas in the right activation map a large area of conduction delay is present in the middle left part of the
activation map. Isochrones are drawn at 10ms. The black arrow indicates the main trajectories of activation. Abbreviation as in Figure 1.
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CTs between 4 and 66 ms measured from both atria in
the entire study population. Patients with AF had
more CTs $4 ms compared to patients without AF
(14.9% [11.8 to 17.0] vs. 12.8% [10.9 to 14.6],
p < 0.001). These differences in CT incidences
became even more pronounced at CTs $6 ms.
Comparing the frequency of CTs for each location
separately showed that at BB, LA, and PVA, slowing of
conduction (CT $4 ms) occurred more frequently in
patients with AF (BB: 20.5% [14.0% to 26.2%] vs.
15.2% [11.8% to 19.5%], p < 0.001; LA: 10.0% [7.0% to
13.3%] vs. 9.0% [6.5% to 11.9%], p ¼ 0.045; PVA:
13.4% [9.0% to 17.6%] vs. 10.9% [8.4% to 14.1%],
p ¼ 0.001). No differences in the amount of CTs $4 ms
were found at RA (p > 0.05).
IMPACT OF AF HISTORY ON THE SEVERITY OF
CONDUCTION DISORDERS. Figure 4 shows the
magnitude of CTs in patients with and without an AF
history for the entire study population (upper panel).Each patient in both groups had at least a CT $16 ms.
A considerable overlap in magnitude of CTs between
patients with and without a history of AF is observed
up to a CT $50 ms. However, more patients with AF
had prolonged CTs $50 ms compared to patients
without AF (CTs $50 ms: n ¼ 54.7% vs. n ¼ 34.4%,
Bonferroni corrected p < 0.004).
The lower panel of Figure 4 shows the magnitude
of CTs in patients with and without an AF history for
each separate location. In the RA, 1 patient had a CT
of even 148 ms. Figure 5 shows the color-coded acti-
vation map of this specific patient including a CT map
of $140 ms indicated by the thick black lines. Atrial
electrograms (right panel) consist of long double po-
tential reflecting the 2 wavefronts propagating along
both sides of the line of block. As shown in the lower
panel of Figure 4, the magnitude of CTs only differed
at BB. At this site, more patients with AF had pro-
longed CTs (CT $30 ms: n ¼ 56.2% vs. n ¼ 36.0%,
Bonferroni corrected p < 0.004). Overall, RA, PVA,
FIGURE 3 Frequency of Conduction Disorders in Patients With and Without AF
The upper left panel shows a color-coded activation map of a patient without AF. The sinus rhythm wavefront propagates without encoun-
tering any areas of conduction disorders. The upper right panel shows a color-coded activation map of a patient with AF and an area of
conduction delay in the upper right part of the activation map reflected by crowding of isochrones. CT maps constructed using various CT values
are depicted next to the corresponding activation map. Isochrones are drawn at 10ms. The black arrows indicate the main trajectories of
activation. The lower panel shows bi-atrial relative frequency distribution of CTs between patients with and without an AF history. AF ¼ atrial
fibrillation; other abbreviations as in Figure 1.
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FIGURE 4 Severity of Conduction Disorders in Patients With and Without AF
The upper panel shows magnitude of CTs measured in patients with and without an AF history for the entire study population. The lower panel
shows magnitude of CTs measured in patients with and without an AF history for each location separately. The left side shows patients in the
no-AF group, and the right side patients in the AF group. *Bonferroni corrected p < 0.004. †Bonferroni corrected 0.004. Abbreviations as in
Figures 1 and 3.
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FIGURE 5 Example of a Severe Conduction Disorder
A color-coded activation map with a severe conduction delay of 140 ms indicated by the
thick black lines. The corresponding atrial electrograms around this line of conduction
block are depicted next to the activation map. There are 2 wavefronts propagating along
the line of conduction block; 1 is propagating from the left upper corner at T ¼ 0 ms ending
in the right lower corner at T ¼ 43 ms, and another propagating from the left upper corner
at T ¼ 142 ms to the right middle corner at T ¼ 153 ms. Hence, there is a line of block
of $140 ms. The recording shows a long double potential representing the 2 wavefronts
that propagates along both sides of the line of block at different times. Isochrones are
drawn at 10 ms. The black arrow indicates the main trajectories of activation. The red
dashed line indicates the steepest negative deflection. Abbreviation as in Figure 1.
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1851and LA show no differences in magnitude of con-
duction disorders (RA: p $ 0.004, LA: p $ 0.006, PVA:
p $ 0.006, all Bonferroni corrected).
DISCUSSION
KEY FINDINGS. This high-resolution intra-operative
mapping study during sinus rhythm is the first to
investigate the impact of various UHD and prior AF
episodes on epicardial atrial CTs throughout both
atria (Central Illustration) . By comparing the 3 UHDs,
the frequency and severity of conduction disorders
did not differ. Patients with AF had more conduction
disorders than patients without AF throughout both
atria. More severe conduction disorders were found
in patients with AF at BB.
THE RELATION OF UHDs AND CONDUCTION DIS-
ORDERS. No differences were found in the frequency
and severity of conduction disorders between pa-
tients with iVHD, IHD, and CHD. As mentioned
earlier, all 3 UHDs are known to cause structural
remodeling. In patients with IHD, conduction disor-
ders leading to arrhythmias are, for example, caused
by inflammation, atherosclerosis, and myocardial
infarction (6–8). Additionally, both VHD and CHD are
associated with atrial pressure and/or volume over-
load, leading to structural changes in the atria (5,20).
Chronic atrial stretch in both groups eventually leads
to conduction disorders because of increased inter-
stitial connective tissue, fibrotic changes, and myo-
cyte alterations (5,21,22). In patients with CHD, the
pressure and/or volume overload usually extents for
decades. Additionally, impaired electrical connec-
tions may be present because of the underlying
congenital heart defect itself (20).
A previous mapping study by Mouws et al. (15)
investigated conduction disorders across BB between
patients with VHD and IHD in a smaller study popu-
lation. They examined the frequency of CTs between
7 to 11 ms and $12 ms and also found that conduction
disorders were equally present between IHD and
VHD. Patients with CHD did not have the most or the
most severe conduction disorder compared to VHD
and IHD despite the long time-course of the disease. A
possible explanation may be that in our study popu-
lation, patients with CHD (median age (IQR) age: 52
(range: 41 to 61) years) were younger than patients
with IHD an iVHD (median age (IQR) age: 67 (60 to 72)
years, p < 0.001 and 70 (63 to 76) years, p < 0.001,
respectively).
THE RELATION BETWEEN AF AND CONDUCTION
DISORDERS. Our study showed that more conduc-
tion disorders were found in patients with AF.Previous studies have also demonstrated that pa-
tients with AF have more conduction disorders, but
the study populations were smaller and only BB or
PVA were investigated. Moreover, they measured
differences in CTs $7 ms and/or $12 ms (13,14). At BB,
Teuwen et al. (14) found an association between
paroxysmal AF and a CT of $12 ms. Albeit, in this
study merely 13 patients of 185 had a history of
paroxysmal AF (14). Mouws et al. (13) showed that the
prevalence of $12 ms at PVA is higher in patients with
AF. Both studies at BB and PVA are consistent with
our findings.
A previous mapping study by Lanters et al. (23)
found that the prevalence of CTs $7 ms and $12 ms
was low in patients without AF (1.4% [range: 0.2% to
4.0%] and 1.3% [range: 0.1% to 4.3%], respectively).
Despite the low prevalence, a considerable intra-
atrial variation already was found, with a predilec-
tion site at the superior intercaval region and to a
lesser extent BB (23). However, the impact of prior AF
episodes was not investigated. In our study, we
compared the prevalence of intra-atrial conduction
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Heida, A. et al. J Am Coll Cardiol EP. 2020;6(14):1844–54.
It is unknown whether intra-atrial conduction during sinus rhythm throughout the atria differs between patients with various underlying heart diseases or is influenced
by atrial fibrillation episodes (left upper panel). This high-resolution epicardial mapping (right panel) revealed that atrial conduction is affected by prior AF episodes,
particularly at BB (lower left panel). BB ¼ Bachmann’s bundle; CT ¼ conduction time; iVHD ¼ (ischemic and) valvular heart disease; LA ¼ left atrium; LAA ¼ left atrial
appendage; LAT ¼ local activation time; PVA¼ pulmonary vein area; PVL ¼ left pulmonary vein; PVR¼ right pulmonary RA ¼ right atrium; RAA ¼ right atrial appendage;
SVC ¼ superior vena cava.
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Patients with AF had more conduction disorders at BB
and LA, and more severe conduction disorders at RA
and BB compared to patients without AF.
A mapping study by Allessie et al. (24) investigated
the electropathological substrate of AF by comparing
patients with persistent AF (duration of >1 year) and
induced AF. In this study, conduction block lines
(CT $ 12 ms) in both AF groups changed continuously
on a beat-to-beat basis throughout the atria (24).
Furthermore, at the RA, longer lines of conduction
block and a higher frequency of conduction block
were found in patients with persistent AF compared
to those with induced AF (24). This indicates that for
AF maintenance both the frequency and severity of
conduction disorders are important. Long lines of
conduction block present during sinus rhythm result
in large CTs because a wavefront takes longer to
propagate around a line of conduction block and
activate the other side. Thus, initiation of re-entry is
facilitated as the likelihood of the rotating wavefrontencountering excitable tissue increases. In our pop-
ulation, CTs were as large as 142 ms.
As previously described, the high-rate AF
episode itself induces atrial remodeling on a
structural and electrical level. Electrical remodeling
is reversible within a week of sinus rhythm, unlike
structural remodeling, which is still partially pre-
sent after 4 months of sinus rhythm (11,25). Struc-
tural remodeling consists of atrial fibrosis, side-to-
side cell uncoupling, or atrial enlargement (2,5,26).
In our data, LA enlargement was more present in
patients with AF compared to patients without AF.
However, also UHDs such as VHD and CHD are as
such well-known risk factors which contribute to
the development of the arrhythmogenic substrate
(27). In the present study we did not find any dif-
ferences in UHDs between patients with VHD, CHD,
and IHD.
BACHMANN’S BUNDLE AS A PREDILECTION SITE
FOR CONDUCTION DISORDERS. Differences in
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: Knowledge of
the prevalence and severity of conduction disorders caused by
structural remodeling during sinus rhythm is the first step in
detection of the arrhythmogenic substrate associated with
development of AF. At present, it is unknown whether intra-
atrial conduction during sinus rhythm throughout the atria differs
between patients with various underlying heart diseases or is
influenced by AF episodes.
TRANSLATIONAL OUTLOOK: Atrial conduction is affected by
prior AF episodes, particularly at BB. These alterations may
provide an arrhythmogenic substrate for AF development and
maintenance. UHD does not affect atrial conduction.
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1853frequency and severity of conduction disorders in
patients with AF were found at all locations, but
particularly at BB. BB is an inter-atrial muscular
bundle consisting of parallel arranged myocardial
strands and myofibers connecting the right side to
the septum spurium and the left side to the left
atrioventricular ring, which continues into the
posterior LA wall including the pulmonary veins
(28). Hence, BB is more attached to the LA than to
the RA and therefore considered more sensitive to
LA overload. In our study, enlarged LA were more
prevalent in patients with AF, which may explain
why this is a predilection site for conduction dis-
orders in patients with AF. Furthermore, because of
its fiber orientation, BB is considered a highway for
intra-atrial conduction (28,29). However, the fibers
are not enclosed by a fibrous tissue sheet and
therefore disrupt more easily by pressure and vol-
ume overload (30).
IMPACT OF SINO-ATRIAL NODE EXIT PATHWAYS ON
CONDUCTION DISORDERS. During sinus rhythm, the
activation origin is dynamic, as the impulse usually
reaches the atrial myocardium via the superior exit
pathway at higher heart rates and via the inferior
pathway at slower heart rates (31). In our data, sinus
rhythm frequencies varied between patients. With
different heart rates, a different exit pathway may
occur. This in turn may change the wavefront direc-
tion and possibly alter the amount of conduction
disorders.
STUDY LIMITATIONS. There is a limited number of
patients with CHD compared to IHD and iVHD.
Comparison of CHD, IHD, and iVHD should therefore
be interpreted with caution. The number of patients
in the AF group is relatively small in comparison
with the no-AF group as it was not always possible
to electrically convert to stable sinus rhythm.
Furthermore, patients with a history of AF had
different degrees of electrical remodeling because
sinus rhythm recordings in some patients were made
immediately after electrical cardioversion, whereas
others were in sinus rhythm for a longer period
before recording all locations. Moreover, at different
sinus rates, different exit pathways occur that can
affect the CTs. Direction-dependent conduction dis-
orders could be missed as we only analyzed sinus
rhythm.
CONCLUSIONS
This high-resolution epicardial mapping study during
sinus rhythm is the first to investigate the impact of
various UHD and AF episodes on epicardial atrial CTsthroughout both atria. By comparing the 3 UHDs, no
differences were found in the frequency and severity
of conduction disorders. The presence of AF episodes
is associated with more conduction disorders
throughout both atria and with more severe conduc-
tion disorders at BB. These findings indicate that
atrial conduction is affected by prior AF episodes,
particularly at BB, and is not affected by UHD. The
next step will be to determine the relevance of these
conduction disorders for AF development and
maintenance.
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